2007 Molecular Biology of Hepatitis B Viruses Meeting

2007年乙型肝炎病毒分子生物学会议

• 批准号: 7333169
• 负责人: William Mason
• 金额: $ 3万
• 依托单位: HEPATITIS B FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2008-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7333169
• 关键词: Address; Antiviral Agents; Basic Science; Biology; Cellular biology; Clinical; Communication; Daily; Educational workshop; Foundations; Funding; Hepatitis B; Hepatitis B Virus; Hepatitis D; Hepatitis Delta Virus; Home environment; Immune response; Immunity; Infection; Metabolism; Minority; Molecular Biology; Numbers; Oral; Public Health; RNA; Research Personnel; Schedule; Scientist; Series; Simian B disease; Structure; Therapeutic; Time; Underrepresented Minority; United States National Institutes of Health; Universities; Vaccinated; Vaccines; Work; cost; posters; prophylactic; virus host interaction

This is a proposal applying for funds to help defray the cost of the 2007 Molecular Biology of Hepatitis B Viruses Meeting, scheduled for Sept. 16th to 20th, 2007. This is the next scheduled meeting in an annual series that has been held continuously since 1985. These are the definitive meetings in this field, which bring together basic scientists in the field of hepatitis B virus (HBV) and hepatitis D (delta) virus (HDV) from throughout the entire world. HBV continues to be a major global and US public health problem. Despite the availability of prophylactic vaccines, many new infections occur daily, partly because of the lack of an immune response in up to 10% of vaccinated people, but mostly because of underutilization of the vaccines, due to cost and other issues. Moreover, for the more than 350 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, every minute 1-2 people in the world die of HBV/HDV. It is thus critical that basic research continues and communication be nurtured among those working in the field. This is the annual meeting at which this interchange occurs. The meeting in 2007 will enhance interaction and dialog, through the 10 oral scientific sessions and 2 poster sessions that provide ample time for discussion, as well as less structured ?networking? time. A theme for this meeting will be host-virus interactions, with a special emphasis on cell biology, RNA metabolism, and antiviral immunity. This will be facilitated by two keynote addresses and a special workshop focused on biology and clinical importance of occult HBV infection. As always, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2006 and for 2007 and beyond, in terms of providing a permanent home for organizing the meeting and making its staff available for organizing the meeting and publicizing it, especially to universities with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs of junior scientists is requested. Limited support for meeting materials and organizational functions is also needed.

这是一份申请资金的提案，以帮助支付2007年分子大会的费用 乙肝病毒生物学会议，定于9月1日举行。2007年16日至20日。这是 每年连续举行的年度会议中的下一次预定会议 1985年。这些是这一领域的权威会议，聚集了基础科学家 在整个乙肝病毒(乙肝)和丁型肝炎(三角洲)病毒(HDV)领域 整个世界。乙肝病毒仍然是全球和美国的主要公共卫生问题。 尽管有预防性疫苗可用，但许多新感染每天都会发生，部分原因是 因为多达10%的接种疫苗的人缺乏免疫反应，但 主要是因为疫苗未得到充分利用，由于成本和其他问题。 此外，对于已经慢性感染乙肝病毒的3.5亿多人来说， (其中约1500万人同时感染HDV)，疫苗没有 治疗价值。因此，世界上每分钟就有1-2人死于HBVHDV。它是 因此，继续进行基础研究和培养这些人之间的交流至关重要 在地里干活。这是发生这种交流的年度会议。这个 2007年会议将加强互动和对话，通过10次科学的口头交流 会议和2个海报会议，提供充足的讨论时间，以及更少的讨论 结构化？网络？时间到了。这次会议的主题将是主机与病毒的相互作用， 特别强调细胞生物学、RNA新陈代谢和抗病毒免疫。这将是 由两位主旨演讲和一个侧重于生物学和 隐匿性乙肝病毒感染的临床意义。一如既往地，我们做出了巨大的努力 将会议成本降至最低。此外，乙肝基金会已经做出了一项 坚定承诺自2006年以来和2007年及以后支持本次会议， 为组织会议和安排工作人员提供永久住所的条款 可用于组织和宣传会议，特别是对有 大量代表不足的少数族裔。为了让初级学生参与 以及少数族裔调查人员，来自NIH的支持，以帮助支付 要求初级科学家。对会议材料和组织的支持有限 函数也是必需的。